Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan for Moderate Ischemic Mitral Regurgitation in CABG Patients
NCT06917664Phase 4Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in Ischemic mitral regurgitation (IMR), sponsored by National Center for Cardiovascular Disease. Started Jun 2025; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
Ischemic mitral regurgitation (IMR)
Beyond the preview
Go deeper on NCT06917664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06917664.